How did ABVC's Q3 2023 earnings compare to forecasts?

ABVC BioPharma's Q3 2023 earnings were not as expected, with the company reporting a net loss of $3.37 million for the quarter. This was a significant decline from the previous quarter's net income of $2.1 million, indicating a challenging period for the company. The actual earnings fell short of the forecast, raising concerns among investors and analysts about the company's financial performance and future prospects.

|code|Ticker|Name|Date|Net Income YoY|Net Income|market_code|
|---|---|---|---|---|---|---|
|ABVC|ABVC.O|ABVC BioPharma|2022 Q4|34.782088316915235|-4500902|186|
|ABVC|ABVC.O|ABVC BioPharma|2023 Q1|68.83459285779406|-1897230|186|
|ABVC|ABVC.O|ABVC BioPharma|2023 Q2|-18.89209498324118|-2315225|186|
|ABVC|ABVC.O|ABVC BioPharma|2023 Q3|10.815342362447584|-3368080|186|